Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

7.1%

1 terminated out of 14 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

5 of 10 completed with results

Key Signals

5 with results91% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (14)

Trial Status

Completed10
Not Yet Recruiting2
Terminated1
Recruiting1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (14)

Research Network

Activity Timeline